← back to search

Shen Yin

Hospital Universitario La Paz ·
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, and Chronic Lymphocytic Leukemia Research.
h-index
17
citations
1,278
works
61
NIH funding
primary concept
Medicine
email

Recent publications

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
The Lancet Oncology 2022cited by 418position: middledoi
In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response
Nature Communications 2022cited by 54position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Matthew J. Matasar · Rutgers, The State University of New Jersey1 papers (2022–2022)Sascha Dietrich · Research Institute of Radiology1 papers (2022–2022)Michael C. Wei · The Royal Melbourne Hospital1 papers (2022–2022)Chan Y. Cheah · The University of Western Australia1 papers (2022–2022)Sarit Assouline · The Quebec Population Health Research Network1 papers (2022–2022)Antonia Kwan · Acentech (United States)1 papers (2022–2022)Nancy L. Bartlett · City of Hope1 papers (2022–2022)Matthew Ku · City of Hope1 papers (2022–2022)Stephen J. Schuster · Goethe University Frankfurt1 papers (2022–2022)Lihua E. Budde · City Of Hope National Medical Center1 papers (2022–2022)John Kuruvilla · University of Toronto1 papers (2022–2022)Chi‐Chung Li · Amgen (United States)1 papers (2022–2022)Elicia Penuel · Acentech (United States)1 papers (2022–2022)Huang Huang · Sun Yat-sen University Cancer Center1 papers (2022–2022)Pratyush Giri · Royal Adelaide Hospital1 papers (2022–2022)Laurie H. Sehn · BC Cancer Agency1 papers (2022–2022)Loretta J. Nastoupil · The University of Texas MD Anderson Cancer Center1 papers (2022–2022)Miguel Canales · Navarre Institute of Health Research1 papers (2022–2022)Keith Fay · St Vincent's Hospital Melbourne1 papers (2022–2022)